News Ajanta Pharma Limited Bombay S.E.

Equities

AJANTPHARM

INE031B01049

Delayed Bombay S.E. Other stock markets 06:10:48 10/05/2024 BST			5-day change	1st Jan Change
2,404 ^INR	-0.25%		+1.02%	+15.20%

05-03	INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	RE
05-02	Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	05-03	RE
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	05-02	MT
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-02	CI
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-02	CI
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.	05-02	CI
Transcript : Ajanta Pharma Limited, Q4 2024 Earnings Call, May 02, 2024	05-02
Ajanta Pharma Limited authorizes a Buyback Plan.	05-01	CI
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	04-25	CI
Ex-dividend day for interim dividend	02-07	FA
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02-02	MT
Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024	01-31
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	01-31	CI
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-31	CI
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	01-25	MT
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31/10/23	CI
Transcript : Ajanta Pharma Limited, Q2 2024 Earnings Call, Oct 31, 2023	31/10/23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31/10/23	CI
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31/08/23	MT
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30/08/23	CI
Ex-dividend day for extraordinary dividend	03/08/23	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ajanta Pharma Limited Bombay S.E.

Equities

AJANTPHARM

INE031B01049

Summary

Filters